Artificial intelligence-enabled post-processing software is dramatically reducing cardiac imaging analysis times while improving consistency and collaboration between radiologists and cardiologists, according to Laura Dragonetti, MD, cardiac radiologist, internal medicine specialist and head, Cardiac Radiology Department at Alemán Hospital in Buenos Aires, Argentina.

Work-related musculoskeletal disorders are a major safety concern in the field of echocardiography, impacting up to 90% of all cardiac sonographers.

U.S. News & World Report has released its latest ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. There are similarities—and some key differences—between this year's list and last year's list.

Treating asymptomatic patients with TAVR may cost more at first, but it appears to be a wise financial decision as time goes on.

The new recall includes multiple lots of dabigatran etexilate capsules.

ACC created a Medicare payment calculator for practices to see the possible impacts on their 2027 payments.

A new drug delivery system may help reduce heart failure hospitalizations and related healthcare costs, which are expected to reach $70 billion by 2030.

The investigational drug down regulates WISPER, a heart stress-specific lncRNA that is overexpressed in hypertrophic cardiomyopathy cardiac fibrosis.

Low-risk patients face comparable outcomes after TAVR and SAVR, researchers wrote, making it important to highlight even the smallest differences between these two approaches. 

The company's flagship technology was invented by Peter Spector, MD, a practicing electrophysiologist. It uses advanced electrodes to visualize details of AFib typically missed by other mapping systems.